Amid covid surge, Iran cut corners to approve yet-unproven vaccine (Washington Post)

Amid covid surge, Iran cut corners to approve yet-unproven vaccine

As Iranian regulators considered endorsing a locally developed coronavirus vaccine a year ago, a top health official issued a stern warning, saying the test results were insufficient and the vaccine’s approval could undermine efforts to contain the country’s raging epidemic.

Deputy Health Minister Farid Najafi wrote to his boss that allowing use of the vaccine by the general public before it met scientific standards “is a serious and historic decision that will determine the future of public confidence in the health system.”

But the vaccine had influential backers. It was the highly touted project of a company called Barkat, part of a sprawling corporate empire close to Iran’s supreme leader, Ayatollah Ali Khamenei.

...

In March of the following year, Mokhber said the company was now prepared to mass-produce the vaccine. “We promise to the beloved Iranian nation that in 2½ months, we won’t have to worry about vaccine shortage in this country,” he said.

Iranian officials portrayed this endeavor as a point of national pride that would catapult Iran into an elite group of scientifically advanced countries. After the government’s troubled response in the early days of the pandemic, much of the Iranian media devoted wide and favorable coverage to Barkat’s project.

“There’s a desire to record a win for the supreme leader,” said Amir Afkhami, a professor and expert on Iranian public health at George Washington University. “On top of that, there’s a financial gain and the financial power and the revenue stream that Setad provides for Khamenei.”

Read the full article on WashingtonPost.com

Latest News

The GW Medical Faculty Associates is pleased to announce that Steven W. Boyce, MD, will serve as Chief of the Division of Cardiac Surgery. He also serves as a Professor of Surgery. The division, which is part of the larger Department of Surgery, is home to a broad group of nationally and…
Air quality in the Washington, D.C. area is unusually poor, and while it may be invisible some days, the threat is still there. Daniel Baram, MD, associate professor of medicine at the George Washington (GW) School of Medicine and Health Sciences (SMHS) and division Director of Pulmonary Medicine…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce the selection of Karen A. Fagan, MD, to serve as the Chair of the GW Department of Medicine.